Financhill
Back

Blueprint Medicines Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Blueprint Medicines Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 99.66 Buy
20-day SMA: 93.45 Buy
50-day SMA: 94.81 Buy
200-day SMA: 97.03 Buy
8-day EMA: 101.17 Buy
20-day EMA: 96.44 Buy
50-day EMA: 94.26 Buy
200-day EMA: 92.14 Buy

Blueprint Medicines Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.15 Buy
Relative Strength Index (14 RSI): 69.84 Buy
Chaikin Money Flow: 891346 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.35 - 99.95) Buy
Bollinger Bands (100): (86.7 - 97) Buy

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Blueprint Medicines Stock

Is Blueprint Medicines Stock a Buy?

BPMC Technical Analysis vs Fundamental Analysis

Sell
45
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy or a Sell?

Blueprint Medicines Stock Info

Market Cap:
7B
Price in USD:
110.05
Share Volume:
970.1K

Blueprint Medicines 52-Week Range

52-Week High:
121.90
52-Week Low:
72.24
Sell
45
Blueprint Medicines (BPMC) is a Sell

Blueprint Medicines Share Price Forecast

Is Blueprint Medicines Stock a Buy?

  • Blueprint Medicines share price is 110.05 while BPMC 8-day exponential moving average is 101.17, which is a Buy signal.
  • The stock price of BPMC is 110.05 while Blueprint Medicines 20-day EMA is 96.44, which makes it a Buy.
  • Blueprint Medicines 50-day exponential moving average is 94.26 while BPMC share price is 110.05, making it a Buy technically.
  • BPMC stock price is 110.05 and Blueprint Medicines 200-day simple moving average is 92.14, creating a Buy signal.

Fundamental Analysis of Blueprint Medicines

Is Blueprint Medicines a good investment?

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $2.89 per share.

Technical Analysis of Blueprint Medicines

Should I short Blueprint Medicines stock?

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.